Posology: Adults (including the elderly): Recommended therapy is one eye drop in the affected eye(s) once daily.
If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.
Paediatric population: The safety and efficacy of Xalacom in children and adolescents has not been established.
Method of administration: Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes (see Precautions).
If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity.